My wish for our type A meeting ...
I am still supremely confident that Mesoblast will eventually start getting ticks & approvals from the fda...
my hope for this meeting is that whilst
1. providing the extra data which proves the stock of remestemcel-L for commercialisation is the the same or very similar to the cells that were provided in our recent trials..
2. we go into this meeting with a back up , with adults trials ready to go ( in short course )
I hope that our trials begin very soon , because wether we can or cannot prove/ convince the fda with the new potency data presented that we deserve an Accelerated Approval ... then at least we are already moving forward towards a rapid outcome from a short trial to finally get us Full Approval ...
mesoblast deserves a break and the kids and adults with SR aGVHD deserve a break we the long term holders deserve a break...
It gives me great confidence that the CEO , CMO and board of directors have all agreed to substantial cuts to their fees and instead they will be receiving Long Term Incentives ... I like this!!!
Cell Therapy News/Articles, page-16799
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.060(5.33%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.14 | $1.07 | $5.556M | 5.065M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 193123 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 300057 | 2 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.07 |
Change
-0.060 ( 5.22 %) |
||||
| Open | High | Low | Volume | ||
| $1.13 | $1.14 | $1.07 | 1328053 | ||
| Last updated 15.59pm 05/06/2024 ? | |||||
| MSB (ASX) Chart |